NEW YORK Aug. 16 2016 PRNewswire &160;Immune Pharmaceuticals Inc. NASDAQIMNP "Immune" or the "Company" announced financial results for the second quarter and six months ended June 30 2016 as well as provided pipeline highlights and ...
↧